Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

Pfizer sells further shares in Sensodyne maker Haleon for £2.4bn - Haleon was formed in 2019 by the merger of the consumer ...

Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6% ...

(Reuters) -Haleon plans to increase its stake in its Chinese joint venture to 88% from 55%, the British consumer healthcare ...

Energycategory Chevron to sell assets for $6.5 bln to Canadian Natural Resources 4:44 PM UTC Energycategory Equinor buys 9.8% stake in offshore wind developer Orsted 5:58 PM UTC Canada's main ...

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

Pfizer has sold a stake in British consumer healthcare group Haleon worth about $3.26 billion, cutting its shareholding in ...

Whether $5 or $50, every contribution counts. US drugs giant Pfizer has sold a stake in Sensodyne and Panadol maker Haleon worth around £2.4 billion, cutting its holding from 22% to 15%.

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of GSK and US rival Pfizer, but was spun out and floated in 2022. US drugs giant Pfizer has sold a stake in Sensodyne ...

By Shanima A (Reuters) -Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and ...